Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection

BACKGROUND: Hepatitis E virus (HEV) infection is a cause of chronic hepatitis in immunosuppressed patients. Sustained virologic response rates to a 12-wk course of ribavirin therapy were reported to be > 70% in the West. This study describes the outcome of HEV treatment in a transplant center in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Hepatol
Autors principals: Low, En Xian Sarah, Tripon, Edhel, Lim, Kieron, Tan, Poh Seng, Low, How Cheng, Dan, Yock Young, Lee, Yin Mei, Muthiah, Mark, Loo, Wai Mun, Koh, Calvin Jianyi, Phyo, Wah Wah, Pang, JunXiong, Lim, Seng Gee, Lee, Guan-Huei
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2019
Matèries:
Retrospective Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6603503/
https://ncbi.nlm.nih.gov/pubmed/31293723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v11.i6.553
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars